Phaarmasia Limited (BOM:523620)
India · Delayed Price · Currency is INR 82.60
-3.20 (-3.73%)
At close: Sep 4, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 563.91 million as of September 4, 2026. Its market cap has increased by 154.94% in one year.
Market Cap
563.91M
Enterprise Value
465.28M
Revenue
486.17M
Ranking
n/a
PE Ratio
3.20
Stock Price
82.60
ChartMarket Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 563.91M, an increase of 4,015.45%. That is a compound annual growth rate of 13.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 563.91M | -26.73% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Godavari Drugs | 798.31M |
| Source Natural Foods and Herbal Supplements | 685.85M |
| Onyx Biotec | 679.96M |
| Shelter Pharma | 532.04M |
| Biofil Chemicals and Pharmaceuticals | 515.88M |
| Parmax Pharma | 495.54M |
| Mangalam Drugs & Organics | 480.39M |
| ANG Lifesciences India | 445.16M |